NKGen Biotech, Inc.
NKGN
$0.06
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.81M | 3.54M | 4.01M | 4.37M | 4.39M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.67M | 5.10M | 6.79M | 7.46M | 7.62M |
| Operating Income | -4.67M | -5.10M | -6.79M | -7.46M | -7.62M |
| Income Before Tax | 15.35M | -29.36M | 6.60M | -16.09M | -5.38M |
| Income Tax Expenses | -- | 53.00K | -- | -- | -- |
| Earnings from Continuing Operations | 15.35M | -29.41M | 6.60M | -16.09M | -5.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.35M | -29.41M | 6.60M | -16.09M | -5.38M |
| EBIT | -4.67M | -5.10M | -6.79M | -7.46M | -7.62M |
| EBITDA | -4.33M | -4.81M | -6.49M | -7.16M | -7.33M |
| EPS Basic | 0.33 | -0.74 | 0.23 | -0.67 | -0.25 |
| Normalized Basic EPS | 0.21 | -0.23 | -0.22 | -0.68 | -0.15 |
| EPS Diluted | -0.04 | -0.74 | 0.15 | -0.67 | -0.25 |
| Normalized Diluted EPS | 0.09 | -0.23 | -0.16 | -0.68 | -0.15 |
| Average Basic Shares Outstanding | 45.96M | 39.98M | 29.13M | 24.17M | 21.94M |
| Average Diluted Shares Outstanding | 102.65M | 39.98M | 41.33M | 24.17M | 21.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |